More than 80 percent of the 200 COVID-19 A new study published in the Endocrine Society shows that patients in a Spanish hospital are deficient in vitamin D. Journal of Clinical Endocrinology and Metabolism.
Vitamin D is a hormone produced by the kidneys that regulates the concentration of calcium in the blood and affects the immune system. Vitamin D deficiency has been linked to a variety of health concerns, although research into why the hormone affects other systems in the body is still ongoing. Many studies point to the beneficial effects of vitamin D on the immune system, especially in relation to protection against infection.
“One approach is to identify and treat vitamin D deficiency, especially in high-risk individuals such as the elderly, patients with comorbidities and nursing home residents who are the main target population of Covid-19,” said the study co-authors. Jose L., Ph.D., from the University of Cantabria in Santander, Spain. Hernandez. “Vitamin D treatment should be recommended in COVID-19 patients with low levels of circulating vitamin D in the blood because this approach may have beneficial effects on both the musculoskeletal and immune systems.”
The researchers discovered 80 percent of the 216 COVID-19 patients at the Spital University Marcus de Valdesila, and had lower levels of vitamin D in men than in women. Serum levels of inflammatory markers such as ferritin and D-dimer were also increased in Covid-19 patients with low vitamin D levels.
Reference: “Vitamin D status in SARS-Cove-2 infected hospitalized patients” 27 October October 2020, Journal of Clinical Endocrinology and Metabolism.
Other authors of the study include: Daniel Nan, Jose M. Olmos, Javier Crespo and Vector M. of Cantabria University. Martinez-Taboda; Marta Fernandez-Aala, Matte Garcia-Unzuta, Miguel A. Hernandez-Hernandez, Marcos López-Hoyos, Manuel Gutierrez-Cuadra, and Juan J. Pedro Museos Raw of Cercio Cantabro de Salud in Santander, Spain;
The manuscript received funding from the Instituto de Salud Carlos III.
